{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:23:25Z","timestamp":1786116205942,"version":"build-2736575974"},"reference-count":161,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Phosphate accounts for about 0.6% of body weight at birth and about 1% of body weight in adults. This anion is essential for the performance of many essential human cellular processes, including energy metabolism and cell signaling; it is also a key component of the phospholipid bilayer and nucleic acids structure. In addition, phosphate is responsible for maintaining acid-base balance within the cells, functioning of the nervous system and preserving bone integrity. Normal serum phosphate levels change throughout life, varying from the neonatal period, through adolescence, and stabilizing at adult values by the end of puberty. Serum phosphate homeostasis is maintained through dietary intake, intra- and intercellular shifts, and excretion\/absorption\/reabsorption processes mediated by Fibroblast Growth Factor 23, parathyroid hormone, and 1,25-(OH)2D3. Within this homeostatic network, dietary sources and current population-based intake data highlight a widespread oversupply in modern diets that can influence chronic disease outcomes. Ultimately, alterations in serum phosphate concentrations lead to numerous pathological conditions, both congenital and acquired. These conditions may involve either hypo- or hyperphosphatemia, each characterized by a wide spectrum of clinical manifestations, some of which primarily affect the musculoskeletal system. Starting from this evidence, the primary purpose of this review is to examine the phosphate-related pathological conditions from biological-molecular and clinical perspectives, while also considering targeted nutritional and clinical strategies for managing phosphate balance. Algorithms for management and differential diagnosis are also considered, thus providing a recent overview of a medical field that is becoming increasingly important for clinicians.<\/jats:p>","DOI":"10.3390\/nu18152568","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T08:08:02Z","timestamp":1786003682000},"page":"2568","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phosphate: An Anion Controlling Metabolic Functions"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0330-2189","authenticated-orcid":false,"given":"Umberto","family":"Tarantino","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences and Translational Medicine, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"},{"name":"Department of Orthopaedics and Traumatology, \u201cPoliclinico Tor Vergata\u201d Foundation, 00133 Rome, Italy"},{"name":"Faculty of Medicine, University \u201cOur Lady of Good Counsel\u201d, 1005 Tirana, Albania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3205-4030","authenticated-orcid":false,"given":"Chiara","family":"Greggi","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics and Traumatology, \u201cPoliclinico Tor Vergata\u201d Foundation, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8264-6961","authenticated-orcid":false,"given":"Beatrice","family":"Gasperini","sequence":"additional","affiliation":[{"name":"Department of Sciences, University Roma Tre, Viale G. Marconi 446, 00146 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0585-1309","authenticated-orcid":false,"given":"Manuel","family":"Scimeca","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Iundusi","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Translational Medicine, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"},{"name":"Department of Orthopaedics and Traumatology, \u201cPoliclinico Tor Vergata\u201d Foundation, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gasbarra","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Translational Medicine, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"},{"name":"Department of Orthopaedics and Traumatology, \u201cPoliclinico Tor Vergata\u201d Foundation, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-0592","authenticated-orcid":false,"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[{"name":"FIRMO Foundation, 50139 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.beem.2018.06.004","article-title":"Phosphate Homeostasis Disorders","volume":"32","author":"Christov","year":"2018","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00223-020-00686-3","article-title":"Phosphate Metabolism in Health and Disease","volume":"108","author":"Peacock","year":"2021","journal-title":"Calcif. Tissue Int."},{"key":"ref_3","unstructured":"Qadeer, H.A., and Bashir, K. (2026). Physiology, Phosphate, NCBI Bookshelf."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.semnephrol.2012.12.018","article-title":"Management of Natural and Added Dietary Phosphorus Burden in Kidney Disease","volume":"33","author":"Cupisti","year":"2013","journal-title":"Semin. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s00467-012-2175-z","article-title":"Phosphate Homeostasis and Its Role in Bone Health","volume":"27","author":"Alon","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"ref_6","first-page":"49","article-title":"Phosphate Additives in Food--a Health Risk","volume":"109","author":"Ritz","year":"2012","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/sdi.12042","article-title":"Contributions to Total Phosphorus Intake: All Sources Considered","volume":"26","author":"Calvo","year":"2013","journal-title":"Semin. Dial."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3945\/ajcn.112.053934","article-title":"Public Health Impact of Dietary Phosphorus Excess on Bone and Cardiovascular Health in the General Population","volume":"98","author":"Calvo","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3945\/ajcn.113.073148","article-title":"High Dietary Phosphorus Intake Is Associated with All-Cause Mortality: Results from NHANES III","volume":"99","author":"Chang","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_10","unstructured":"Sharma, S., Hashmi, M.F., and Castro, D. (2023). Hypophosphatemia, Stat Pearls Publishing."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/112_2020_52","article-title":"Developmental Changes in Phosphate Homeostasis","volume":"179","author":"MacDonald","year":"2021","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.eprac.2022.09.007","article-title":"Phosphatonins: From Discovery to Therapeutics","volume":"29","author":"Kritmetapak","year":"2023","journal-title":"Endocr. Pract."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1681\/ASN.2020010081","article-title":"A Land of Controversy: Fibroblast Growth Factor-23 and Uremic Cardiac Hypertrophy","volume":"31","author":"Bao","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2362.2006.01659.x","article-title":"Emerging Role of a Phosphatonin in Mineral Homeostasis and Its Derangements","volume":"36","author":"Bielesz","year":"2006","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00424-005-1495-2","article-title":"Secreted Frizzled-Related Protein-4 Reduces Sodium-Phosphate Co-Transporter Abundance and Activity in Proximal Tubule Cells","volume":"451","author":"Berndt","year":"2006","journal-title":"Pflug. Arch."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI18563","article-title":"Secreted Frizzled-Related Protein 4 Is a Potent Tumor-Derived Phosphaturic Agent","volume":"112","author":"Berndt","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"115300","DOI":"10.1016\/j.bone.2020.115300","article-title":"Hyperphosphatemia with Low FGF7 and Normal FGF23 and SFRP4 Levels in the Circulation Characterizes Pediatric Hypophosphatasia","volume":"134","author":"Whyte","year":"2020","journal-title":"Bone"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00424-022-02668-w","article-title":"The Regulation of FGF23 under Physiological and Pathophysiological Conditions","volume":"474","author":"Rausch","year":"2022","journal-title":"Pflug. Arch."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/1873-3468.12040","article-title":"Counter-Regulatory Paracrine Actions of FGF-23 and 1,25(OH)2 D in Macrophages","volume":"590","author":"Han","year":"2016","journal-title":"FEBS Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-010-1024-2","article-title":"Hormone-like (Endocrine) Fgfs: Their Evolutionary History and Roles in Development, Metabolism, and Disease","volume":"342","author":"Itoh","year":"2010","journal-title":"Cell Tissue Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.str.2011.10.022","article-title":"The Alternatively Spliced Acid Box Region Plays a Key Role in FGF Receptor Autoinhibition","volume":"20","author":"Kalinina","year":"2012","journal-title":"Structure"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41586-023-06155-9","article-title":"Structural Basis for FGF Hormone Signalling","volume":"618","author":"Chen","year":"2023","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1210\/en.2005-0670","article-title":"Analysis of the Biochemical Mechanisms for the Endocrine Actions of Fibroblast Growth Factor-23","volume":"146","author":"Yu","year":"2005","journal-title":"Endocrinology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","article-title":"FGF23 Decreases Renal NaPi-2a and NaPi-2c Expression and Induces Hypophosphatemia in Vivo Predominantly via FGF Receptor 1","volume":"297","author":"Gattineni","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"F371","DOI":"10.1152\/ajprenal.00740.2010","article-title":"Regulation of Serum 1,25(OH)2 Vitamin D3 Levels by Fibroblast Growth Factor 23 Is Mediated by FGF Receptors 3 and 4","volume":"301","author":"Gattineni","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1038\/ki.2011.27","article-title":"Phosphate and FGF-23","volume":"79","year":"2011","journal-title":"Kidney Int. Suppl."},{"key":"ref_27","first-page":"825","article-title":"The Relation of Age and Sex to Distribution of Values in Healthy Adults of Serum Calcium, Inorganic Phosphorus, Magnesium, Alkaline Phosphatase, Total Proteins, Albumin, and Blood Urea","volume":"73","author":"Keating","year":"1969","journal-title":"J. Lab. Clin. Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"B\u0142aszczyk, J.W. (2023). Metabolites of Life: Phosphate. Metabolites, 13.","DOI":"10.3390\/metabo13070860"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Serna, J., and Bergwitz, C. (2020). Importance of Dietary Phosphorus for Bone Metabolism and Healthy Aging. Nutrients, 12.","DOI":"10.3390\/nu12103001"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EC-20-0509","article-title":"Age-Dependent Sex Differences in Calcium and Phosphate Homeostasis","volume":"10","author":"Koek","year":"2021","journal-title":"Endocr. Connect."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"153865","DOI":"10.1016\/j.metabol.2019.01.006","article-title":"Physiology of FGF23 and Overview of Genetic Diseases Associated with Renal Phosphate Wasting","volume":"103S","author":"Bacchetta","year":"2020","journal-title":"Metabolism"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Tarantino, U., Greggi, C., Visconti, V.V., Cariati, I., Bonanni, R., Gasperini, B., Nardone, I., Gasbarra, E., and Iundusi, R. (2022). Sarcopenia and Bone Health: New Acquisitions for a Firm Liaison. Ther. Adv. Musculoskelet. Dis., 14.","DOI":"10.1177\/1759720X221138354"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"116104","DOI":"10.1016\/j.bone.2021.116104","article-title":"Tunnels in the Rock: Dynamics of Osteocyte Morphogenesis","volume":"153","author":"Moharrer","year":"2021","journal-title":"Bone"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.ajkd.2011.08.035","article-title":"Evaluation of Hypophosphatemia: Lessons from Patients with Genetic Disorders","volume":"59","author":"Bacchetta","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.amjmed.2005.02.014","article-title":"Hypophosphatemia: An Update on Its Etiology and Treatment","volume":"118","author":"Gaasbeek","year":"2005","journal-title":"Am. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncpneph0124","article-title":"Hypophosphatemia: An Evidence-Based Approach to Its Clinical Consequences and Management","volume":"2","author":"Amanzadeh","year":"2006","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s40618-014-0158-6","article-title":"Alpha Klotho and Phosphate Homeostasis","volume":"37","author":"Bian","year":"2014","journal-title":"J. Endocrinol. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1210\/clinem\/dgad210","article-title":"Impaired Physical Performance in X-Linked Hypophosphatemia Is Not Caused by Depleted Muscular Phosphate Stores","volume":"108","author":"Kara","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e1524","DOI":"10.1210\/clinem\/dgad383","article-title":"Development of Spinal Enthesopathies in Adults with X-Linked Hypophosphatemia","volume":"108","author":"Herrou","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A Clinician\u2019s Guide to X-Linked Hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00467-019-04290-y","article-title":"Mineralized Tissues in Hypophosphatemic Rickets","volume":"35","author":"Robinson","year":"2020","journal-title":"Pediatr. Nephrol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"116839","DOI":"10.1016\/j.bone.2023.116839","article-title":"X-Linked Hypophosphatemia Caused by a Deep Intronic Variant in PHEX Identified by PCR-Based RNA Analysis of Urine-Derived Cells","volume":"176","author":"Grimbly","year":"2023","journal-title":"Bone"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0305-0491(98)00026-1","article-title":"Energy Balance in Muscle Activity: Simulations of ATPase Coupled to Oxidative Phosphorylation and to Creatine Kinase","volume":"120","author":"Kushmerick","year":"1998","journal-title":"Comp. Biochem. Physiol. Part B Biochem. Mol. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"E990","DOI":"10.1210\/jc.2012-4146","article-title":"The Muscle-Bone Relationship in X-Linked Hypophosphatemic Rickets","volume":"98","author":"Veilleux","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Dodamani, M.H., Kumar, S.C., Bhattacharjee, S., Barnabas, R., Kumar, S., Ranjan Lila, A., Samad Memon, S., Karlekar, M., A Patil, V., and R Bandgar, T. (2024). Efficacy and Safety of Burosumab Compared with Conventional Therapy in Patients with X-Linked Hypophosphatemia: A Systematic Review. Arch. Endocrinol. Metab., 68.","DOI":"10.20945\/2359-4292-2023-0242"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Bruneau, H., and Bergwitz, C. (2026). Hypophosphatemic Rickets: Diagnosis and Treatment. Arch. Endocrinol. Metab., 70.","DOI":"10.20945\/2359-4292-2026-0044"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.070107","article-title":"FGF23 Concentrations Vary with Disease Status in Autosomal Dominant Hypophosphatemic Rickets","volume":"22","author":"Imel","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"(2000). Autosomal Dominant Hypophosphataemic Rickets Is Associated with Mutations in FGF23. Nat. Genet., 26, 345\u2013348.","DOI":"10.1038\/81664"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00774-009-0111-5","article-title":"An Autosomal Dominant Hypophosphatemic Rickets Phenotype in a Tunisian Family Caused by a New FGF23 Missense Mutation","volume":"28","author":"Gribaa","year":"2010","journal-title":"J. Bone Miner. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00223-020-00755-7","article-title":"Clinical Characteristics and Bone Features of Autosomal Recessive Hypophosphatemic Rickets Type 1 in Three Chinese Families: Report of Five Chinese Cases and Review of the Literature","volume":"107","author":"Ni","year":"2020","journal-title":"Calcif. Tissue Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ijos.2012.69","article-title":"Dentin Matrix Protein 1 and Phosphate Homeostasis Are Critical for Postnatal Pulp, Dentin and Enamel Formation","volume":"4","author":"Rangiani","year":"2012","journal-title":"Int. J. Oral Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jbmr.226","article-title":"The Biological Function of DMP-1 in Osteocyte Maturation Is Mediated by Its 57-KDa C-Terminal Fragment","volume":"26","author":"Lu","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.tibs.2019.01.010","article-title":"ENPP1 in the Regulation of Mineralization and Beyond","volume":"44","author":"Roberts","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"116111","DOI":"10.1016\/j.bone.2021.116111","article-title":"Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2) Due to ENPP1-Deficiency","volume":"153","author":"Kornak","year":"2021","journal-title":"Bone"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/jbmr.3938","article-title":"Clinical and Biochemical Phenotypes in a Family with ENPP1 Mutations","volume":"35","author":"Kotwal","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"ref_56","first-page":"967","article-title":"Early Onset Hearing Loss in Autosomal Recessive Hypophosphatemic Rickets Caused by Loss of Function Mutation in ENPP1","volume":"28","author":"Strom","year":"2015","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"ref_57","first-page":"1580","article-title":"Clinical Spectrum of Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH)","volume":"37","author":"Heider","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/499409","article-title":"SLC34A3 Mutations in Patients with Hereditary Hypophosphatemic Rickets with Hypercalciuria Predict a Key Role for the Sodium-Phosphate Cotransporter NaPi-IIc in Maintaining Phosphate Homeostasis","volume":"78","author":"Bergwitz","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00424-018-2184-2","article-title":"Hereditary Hypophosphatemic Rickets with Hypercalciuria: Pathophysiology, Clinical Presentation, Diagnosis and Therapy","volume":"471","author":"Bergwitz","year":"2019","journal-title":"Pflug. Arch."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jsbmb.2016.07.014","article-title":"CYP2R1 Mutations Causing Vitamin D-Deficiency Rickets","volume":"173","author":"Thacher","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1073\/pnas.1315006110","article-title":"CYP2R1 Is a Major, but Not Exclusive, Contributor to 25-Hydroxyvitamin D Production in Vivo","volume":"110","author":"Zhu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/jbmr.3181","article-title":"Vitamin D-Dependent Rickets Type 1B (25-Hydroxylase Deficiency): A Rare Condition or a Misdiagnosed Condition?","volume":"32","author":"Molin","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1073\/pnas.0402490101","article-title":"Genetic Evidence That the Human CYP2R1 Enzyme Is a Key Vitamin D 25-Hydroxylase","volume":"101","author":"Cheng","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1515\/jpem-2021-0403","article-title":"Genotype and Phenotypic Spectrum of Vitamin D Dependent Rickets Type 1A: Our Experience and Systematic Review","volume":"34","author":"Dodamani","year":"2021","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"17101","DOI":"10.1038\/nrdp.2017.101","article-title":"Rickets","volume":"3","author":"Carpenter","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Tran, T.A.T., Dien, T.M., Nguyen, N.L., Nguyen, K.N., Can, T.B.N., Thao, B.P., Hong, N.T.T., Tran, V.K., Tran, T.H., and Khoa, N.X. (2025). Phenotypes and Genotypes of Children with Vitamin D-Dependent Rickets Type 1A: A Single Tertiary Pediatric Center in Vietnam. Diagnostics, 15.","DOI":"10.20944\/preprints202502.2177.v1"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00223-020-00704-4","article-title":"Prolonged 25-OH Vitamin D Deficiency Does Not Impair Bone Mineral Density in Adult Patients with Vitamin D 25-Hydroxylase Deficiency (CYP2R1)","volume":"107","author":"Wiedemann","year":"2020","journal-title":"Calcif. Tissue Int."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1210\/clinem\/dgad034","article-title":"Ultra-High Performance Liquid Chromatography-Mass Spectrometry-Based Serum Metabolomics for Early Diagnosis of Refractory Tumor-Induced Osteomalacia: A Case-Control Study","volume":"108","author":"Li","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"116064","DOI":"10.1016\/j.bone.2021.116064","article-title":"Challenges in the Management of Tumor-Induced Osteomalacia (TIO)","volume":"152","author":"Brandi","year":"2021","journal-title":"Bone"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1210\/endrev\/bnac026","article-title":"Tumor-Induced Osteomalacia: A Comprehensive Review","volume":"44","author":"Minisola","year":"2023","journal-title":"Endocr. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jbmr.4900","article-title":"Burosumab Improves Patient-Reported Outcomes in Adults with Tumor-Induced Osteomalacia: Mixed-Methods Analysis","volume":"38","author":"Cimms","year":"2023","journal-title":"J. Bone Miner. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/j.semdp.2019.07.002","article-title":"Phosphaturic Mesenchymal Tumors: A Review and Update","volume":"36","author":"Folpe","year":"2019","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00223-024-01317-x","article-title":"Treatment Advances in Tumor-Induced Osteomalacia","volume":"116","author":"Hartley","year":"2025","journal-title":"Calcif. Tissue Int."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00223-020-00664-9","article-title":"The Causes of Hypo- and Hyperphosphatemia in Humans","volume":"108","author":"Koumakis","year":"2021","journal-title":"Calcif. Tissue Int."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jbmr.4486","article-title":"An Expert Perspective on Phosphate Dysregulation with a Focus on Chronic Hypophosphatemia","volume":"37","author":"Aljuraibah","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Namestnic, Y., Shwieke, H., Heyman, S.N., and Marcus, E.-L. (2022). Severe Protracted Hypophosphatemia in a Patient with Persistent Vegetative State on Long-Term Assisted Respiratory Support. Am. J. Case Rep., 23.","DOI":"10.12659\/AJCR.934532"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.eprac.2025.07.015","article-title":"Diagnosis and Management of Hypophosphatemic Disorders","volume":"31","author":"Liu","year":"2025","journal-title":"Endocr. Pract."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.soard.2016.01.001","article-title":"Vitamin D Status and Supplementation before and after Bariatric Surgery: A Comprehensive Literature Review","volume":"12","author":"Peterson","year":"2016","journal-title":"Surg. Obes. Relat. Dis."},{"key":"ref_79","first-page":"e16388","article-title":"Secondary Hyperparathyroidism in Chronic Kidney Disease: Pathophysiology and Management","volume":"13","author":"Habas","year":"2021","journal-title":"Cureus"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Brandenburg, V., and Ketteler, M. (2022). Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future. Nutrients, 14.","DOI":"10.3390\/nu14153009"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00467-009-1252-4","article-title":"Post-Renal Transplantation Hypophosphatemia","volume":"25","author":"Sakhaee","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"ref_82","first-page":"205","article-title":"Phosphate Disorders and Clinical Management of Hypophosphatemia and Hyperphosphatemia","volume":"67","author":"Varsavsky","year":"2020","journal-title":"Endocrinol. Diabetes Nutr."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Zhou, C., Shi, Z., Ouyang, N., and Ruan, X. (2021). Hyperphosphatemia and Cardiovascular Disease. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.644363"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00424-022-02691-x","article-title":"Phosphate Intake, Hyperphosphatemia, and Kidney Function","volume":"474","author":"Krapf","year":"2022","journal-title":"Pflug. Arch."},{"key":"ref_85","unstructured":"Goyal, R., and Jialal, I. (2023). Hyperphosphatemia, StatPearls."},{"key":"ref_86","unstructured":"Rout, P., and Jialal, I. (2026). Hyperphosphatemia, StatPearls."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11914-017-0398-4","article-title":"Effects of Excessive Dietary Phosphorus Intake on Bone Health","volume":"15","author":"Vorland","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.semnephrol.2014.09.005","article-title":"New Insights into the FGF23-Klotho Axis","volume":"34","author":"Olauson","year":"2014","journal-title":"Semin. Nephrol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1753-4887.2012.00473.x","article-title":"Dietary Phosphorus in Bone Health and Quality of Life","volume":"70","author":"Takeda","year":"2012","journal-title":"Nutr. Rev."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5858\/arpa.2017-0278-RS","article-title":"Tumor Lysis Syndrome","volume":"143","author":"Williams","year":"2019","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bbcan.2018.04.007","article-title":"Phosphate Toxicity and Tumorigenesis","volume":"1869","author":"Brown","year":"2018","journal-title":"Biochim. Biophys. Acta. Rev. Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1592\/phco.26.3.410","article-title":"Sevelamer Therapy for Pediatric End-Stage Renal Disease","volume":"26","author":"Storms","year":"2006","journal-title":"Pharmacotherapy"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12288-013-0264-1","article-title":"Hypercalcemia in Tumor Lysis Syndrome","volume":"30","author":"Shah","year":"2014","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1053\/j.ackd.2021.09.007","article-title":"Tumor Lysis Syndrome","volume":"28","author":"Barbar","year":"2021","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra0801327","article-title":"Rhabdomyolysis and Acute Kidney Injury","volume":"361","author":"Bosch","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_96","unstructured":"Rout, P., Chippa, V., and Adigun, R. (2026). Rhabdomyolysis, StatPearls Publishing."},{"key":"ref_97","first-page":"58","article-title":"Rhabdomyolysis: Pathogenesis, Diagnosis, and Treatment","volume":"15","author":"Torres","year":"2015","journal-title":"Ochsner J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"56","DOI":"10.12998\/wjcc.v5.i2.56","article-title":"Rhabdomyolysis Following Severe Hypokalemia Caused by Familial Hypokalemic Periodic Paralysis","volume":"5","author":"Jung","year":"2017","journal-title":"World J. Clin. Cases"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Safari, S., Ghasemi, M., Yousefifard, M., Ghasemi, A., and Najafi, I. (2024). Uric Acid in Predicting the Traumatic Rhabdomyolysis Induced Acute Kidney Injury; a Systematic Review and Meta-Analysis. BMC Nephrol., 25.","DOI":"10.1186\/s12882-024-03509-x"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00008.2019","article-title":"Phosphate Transport in Epithelial and Nonepithelial Tissue","volume":"101","author":"Hernando","year":"2021","journal-title":"Physiol. Rev."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/1535370219831220","article-title":"Intestinal Phosphate Absorption: The Paracellular Pathway Predominates?","volume":"244","author":"Saurette","year":"2019","journal-title":"Exp. Biol. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"F1466","DOI":"10.1152\/ajprenal.00279.2009","article-title":"Regulation of Rat Intestinal Na-Dependent Phosphate Transporters by Dietary Phosphate","volume":"297","author":"Giral","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4103\/2230-8210.113752","article-title":"Renal Phosphate Handling: Physiology","volume":"17","author":"Prasad","year":"2013","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/advances\/nmab066","article-title":"Perspective: Plant-Based Whole-Grain Foods for Chronic Kidney Disease: The Phytate-Phosphorus Conundrum","volume":"12","author":"Calvo","year":"2021","journal-title":"Adv. Nutr."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-3-030-91623-7_5","article-title":"Vitamin D and Phosphate Interactions in Health and Disease","volume":"1362","author":"Akimbekov","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","article-title":"Global Epidemiology and Outcomes of Acute Kidney Injury","volume":"14","author":"Hoste","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semnephrol.2018.10.004","article-title":"Dysregulated Mineral Metabolism in AKI","volume":"39","author":"Leaf","year":"2019","journal-title":"Semin. Nephrol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jare.2016.09.006","article-title":"Serum Uric Acid and Acute Kidney Injury: A Mini Review","volume":"8","author":"Hahn","year":"2017","journal-title":"J. Adv. Res."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Jung, S.-Y., Kwon, J., Park, S., Jhee, J.H., Yun, H.-R., Kim, H., Kee, Y.K., Yoon, C.-Y., Chang, T.-I., and Kang, E.W. (2018). Phosphate Is a Potential Biomarker of Disease Severity and Predicts Adverse Outcomes in Acute Kidney Injury Patients Undergoing Continuous Renal Replacement Therapy. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0191290"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e4542","DOI":"10.1097\/MD.0000000000004542","article-title":"Electrolyte and Mineral Disturbances in Septic Acute Kidney Injury Patients Undergoing Continuous Renal Replacement Therapy","volume":"95","author":"Jung","year":"2016","journal-title":"Medicine"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2215\/CJN.11901115","article-title":"Phosphate Toxicity in CKD: The Killer among Us","volume":"11","author":"Ritter","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Vogt, I., Haffner, D., and Leifheit-Nestler, M. (2019). FGF23 and Phosphate-Cardiovascular Toxins in CKD. Toxins, 11.","DOI":"10.3390\/toxins11110647"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/0004563214521399","article-title":"Phosphate Homeostasis and Disorders","volume":"51","author":"Manghat","year":"2014","journal-title":"Ann. Clin. Biochem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"13","DOI":"10.15537\/smj.2015.1.9843","article-title":"Hyperphosphatemia. The Hidden Killer in Chronic Kidney Disease","volume":"36","author":"Askar","year":"2015","journal-title":"Saudi Med. J."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/ndt\/gfy287","article-title":"High-Serum Phosphate and Parathyroid Hormone Distinctly Regulate Bone Loss and Vascular Calcification in Experimental Chronic Kidney Disease","volume":"34","author":"Panizo","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/tcmj.tcmj_36_20","article-title":"Vascular Calcification of Chronic Kidney Disease: A Brief Review","volume":"33","author":"Hsu","year":"2021","journal-title":"Tzu Chi Med. J."},{"key":"ref_117","first-page":"2077","article-title":"Signaling Pathways Involved in Vascular Smooth Muscle Cell Calcification during Hyperphosphatemia","volume":"76","author":"Voelkl","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/j.ajkd.2013.03.042","article-title":"Phosphate Homeostasis in CKD: Report of a Scientific Symposium Sponsored by the National Kidney Foundation","volume":"62","author":"Block","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"121148","DOI":"10.1016\/j.lfs.2022.121148","article-title":"Mechanistic Insights into CKD-MBD-Related Vascular Calcification and Its Clinical Implications","volume":"311","author":"Kaur","year":"2022","journal-title":"Life Sci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1590\/2175-8239-jbn-2020-0243","article-title":"Hypoparathyroidism and Fahr\u2019s Syndrome: Case Series","volume":"44","author":"Arruda","year":"2022","journal-title":"J. Bras. Nefrol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4103\/2230-8210.100637","article-title":"Mucocutaneous Manifestations of Acquired Hypoparathyroidism: An Observational Study","volume":"16","author":"Sarkar","year":"2012","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/j.ajkd.2012.06.026","article-title":"A Physiologic-Based Approach to the Evaluation of a Patient with Hyperphosphatemia","volume":"61","author":"Leaf","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"651","DOI":"10.20945\/2359-3997000000554","article-title":"Treatment Options in Hypoparathyroidism","volume":"66","author":"Sakane","year":"2022","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1210\/jc.2015-3909","article-title":"Presentation of Hypoparathyroidism: Etiologies and Clinical Features","volume":"101","author":"Shoback","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ecl.2018.07.007","article-title":"Genetic Disorders of Parathyroid Development and Function","volume":"47","author":"Gordon","year":"2018","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Liu, X.-J., Yan, C., and Jia, J.-Y. (2019). A Typical 22q11.2 Deletion Syndrome and Pseudohypoparathyroidism: A CARE Compliant Case Report. Medicine, 98.","DOI":"10.1097\/MD.0000000000016109"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1002\/jbmr.4667","article-title":"Hypoparathyroidism: Genetics and Diagnosis","volume":"37","author":"Mannstadt","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"ref_128","unstructured":"Feingold, K.R., Anawalt, B., Blackman, M.R., Boyce, A., Chrousos, G., Corpas, E., de Herder, W.W., Dhatariya, K., Dungan, K., and Hofland, J. (2000). Hypoparathyroidism and Pseudohypoparathyroidism, Endotext."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1530\/EJE-19-0641","article-title":"Should the GCM2 Gene Be Tested When Screening for Familial Primary Hyperparathyroidism?","volume":"182","author":"Coppin","year":"2020","journal-title":"Eur. J. Endocrinol."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Wu, Y., Zhang, C., Huang, X., Cao, L., Liu, S., and Zhong, P. (2022). Autosomal Dominant Hypocalcemia with a Novel CASR Mutation: A Case Study and Literature Review. J. Int. Med. Res., 50.","DOI":"10.1177\/03000605221110489"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Festas Silva, D., De Sousa Lages, A., Caetano, J.S., Cardoso, R., Dinis, I., Gomes, L., Paiva, I., and Mirante, A. (2021). A Variant in the CASR Gene (c.368T>C) Causing Hypocalcemia Refractory to Standard Medical TherapyEndocrinol. Diabetes Metab. Case Rep., 2021.","DOI":"10.1530\/EDM-21-0005"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","article-title":"Homozygous Ablation of Fibroblast Growth Factor-23 Results in Hyperphosphatemia and Impaired Skeletogenesis, and Reverses Hypophosphatemia in Phex-Deficient Mice","volume":"23","author":"Sitara","year":"2004","journal-title":"Matrix Biol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S2213-8587(19)30426-7","article-title":"Approach to Patients with Hypophosphataemia","volume":"8","author":"Florenzano","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Netzer, S., B\u00fcchel, L., B\u00fcchi, A.E., and Aubert, C.E. (2025). Indications for the Evaluation and Supplementation of Hypophosphatemia: An Umbrella Systematic Review of Reviews and Guidelines. BMC Med., 23.","DOI":"10.1186\/s12916-025-04415-1"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI113172","article-title":"Dietary Intake of Phosphorus Modulates the Circadian Rhythm in Serum Concentration of Phosphorus. Implications for the Renal Production of 1,25-Dihydroxyvitamin D","volume":"80","author":"Portale","year":"1987","journal-title":"J. Clin. Investig."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-Induced Osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s40618-019-01165-9","article-title":"FGF23-Related Hypophosphatemia in Patients with Low Bone Mineral Density and Fragility Fractures: Challenges in Diagnosis and Management","volume":"43","author":"Indirli","year":"2020","journal-title":"J. Endocrinol. Investig."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s00198-018-4618-2","article-title":"Phosphate Wasting Disorders in Adults","volume":"29","author":"Marcucci","year":"2018","journal-title":"Osteoporos. Int."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Geerse, D.A., Bindels, A.J., Kuiper, M.A., Roos, A.N., Spronk, P.E., and Schultz, M.J. (2010). Treatment of Hypophosphatemia in the Intensive Care Unit: A Review. Crit. Care, 14.","DOI":"10.1186\/cc9215"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ncp.10474","article-title":"ASPEN Consensus Recommendations for Refeeding Syndrome","volume":"35","author":"Seres","year":"2020","journal-title":"Nutr. Clin. Pract."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/bmj.a301","article-title":"Refeeding Syndrome: What It Is, and How to Prevent and Treat It","volume":"336","author":"Mehanna","year":"2008","journal-title":"BMJ"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/ckj\/sfs173","article-title":"Management of Hyperphosphataemia in Chronic Kidney Disease-Challenges and Solutions","volume":"6","author":"Ketteler","year":"2013","journal-title":"Clin. Kidney J."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Raju, S., and Saxena, R. (2025). Hyperphosphatemia in Kidney Failure: Pathophysiology, Challenges, and Critical Role of Phosphorus Management. Nutrients, 17.","DOI":"10.20944\/preprints202503.2193.v2"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"(2017). Erratum: Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl., 7, 1\u201359.","DOI":"10.1016\/j.kisu.2017.04.001"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive Summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: What\u2019s Changed and Why It Matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Kolcsar, M., Szab\u00f3, L., D\u00e9nes, O.M., and G\u00e1ll, Z. (2024). Assessment of Vitamin D Status in Primary Hyperparathyroidism Patients: A Retrospective Study. Cureus, 16.","DOI":"10.7759\/cureus.64988"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Friedman, E.A. (2005). Consequences and Management of Hyperphosphatemia in Patients with Renal Insufficiency. Kidney Int. Suppl., S1\u2013S7.","DOI":"10.1111\/j.1523-1755.2005.09500.x"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.jrn.2020.02.003","article-title":"Management of Hyperphosphatemia in End-Stage Renal Disease: A New Paradigm","volume":"31","author":"Rastogi","year":"2021","journal-title":"J. Ren. Nutr."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/bonekey.2013.231","article-title":"Phosphate Metabolism and Vitamin D","volume":"3","author":"Fukumoto","year":"2014","journal-title":"Bonekey Rep."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ekir.2019.06.002","article-title":"Strategies for Phosphate Control in Patients with CKD","volume":"4","author":"Barreto","year":"2019","journal-title":"Kidney Int. Rep."},{"key":"ref_151","first-page":"10","article-title":"Phosphate Binders in Patients with Chronic Kidney Disease","volume":"40","author":"Chan","year":"2017","journal-title":"Aust. Prescr."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"D\u2019Alessandro, C., Piccoli, G.B., and Cupisti, A. (2015). The \u201cPhosphorus Pyramid\u201d: A Visual Tool for Dietary Phosphate Management in Dialysis and CKD Patients. BMC Nephrol., 16.","DOI":"10.1186\/1471-2369-16-9"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/IJNRD.S78040","article-title":"Phosphate Binders for the Treatment of Chronic Kidney Disease: Role of Iron Oxyhydroxide","volume":"9","author":"Cernaro","year":"2016","journal-title":"Int. J. Nephrol. Renov. Dis."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/gfw312","article-title":"The Efficacy and Safety of Sevelamer and Lanthanum versus Calcium-Containing and Iron-Based Binders in Treating Hyperphosphatemia in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis","volume":"32","author":"Habbous","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"National Kidney Foundation (2003). K\/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am. J. Kidney Dis., 42, S1\u2013S201.","DOI":"10.1016\/S0272-6386(03)00905-3"},{"key":"ref_156","first-page":"1","article-title":"Management of Hyperphosphatemia in Patients with End-Stage Renal Disease: Focus on Lanthanum Carbonate","volume":"2","author":"Persy","year":"2009","journal-title":"Int. J. Nephrol. Renov. Dis."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/j.ajkd.2026.03.036","article-title":"KDOQI US Commentary on the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in CKD","volume":"88","author":"Jalal","year":"2026","journal-title":"Am. J. Kidney Dis."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/ndt\/17.suppl_2.9","article-title":"The Clinical Impact of Aluminium Overload in Renal Failure","volume":"17","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ajkd.2010.10.055","article-title":"Effect of Sevelamer and Calcium-Based Phosphate Binders on Coronary Artery Calcification and Accumulation of Circulating Advanced Glycation End Products in Hemodialysis Patients","volume":"57","author":"Kakuta","year":"2011","journal-title":"Am. J. Kidney Dis."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1681\/ASN.2016080855","article-title":"Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis","volume":"28","author":"Block","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_161","first-page":"627","article-title":"Burosumab for the Treatment of Tumor-Induced Osteomalacia","volume":"36","author":"Miller","year":"2021","journal-title":"J. Bone Miner. Res."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/15\/2568\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T08:20:33Z","timestamp":1786004433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/15\/2568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":161,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["nu18152568"],"URL":"https:\/\/doi.org\/10.3390\/nu18152568","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}